Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites

Arun Ammayappan1, Rebecca Nace, Kah-Whye Peng

  • 1Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.

Journal of Virology
|January 4, 2013
PubMed

Insights

Engineered vesicular stomatitis virus (VSV) using picornavirus IRES elements significantly reduced neurotoxicity. This modification maintained VSV

Area of Science:

  • Oncolytic virotherapy
  • Viral gene therapy
  • Neurovirology

Background:

  • Vesicular stomatitis virus (VSV) shows promise for cancer treatment.
  • VSV's clinical application is limited by neurotoxicity.
  • Picornaviral internal ribosome entry site (IRES) elements can restrict neuronal activity.

Purpose of the Study:

  • To engineer VSV with picornavirus IRES elements to reduce neuropathogenicity.
  • To assess the impact of IRES elements on VSV neurovirulence and oncolytic potency.

Main Methods:

  • Incorporated IRES elements from human rhinovirus type 2 (HRV2) and foot-and-mouth disease virus (FMDV) into VSV.
  • Controlled the translation of the VSV matrix (M) gene using IRES elements.
  • Evaluated IRES-controlled VSV growth kinetics in vitro and neurovirulence/oncolytic potency in vivo.

Main Results:

  • In vitro studies showed slower growth kinetics for IRES-controlled VSVs in most cell lines.
  • In vivo studies demonstrated severe attenuation of VSV neurovirulence by HRV2 and FMDV IRES elements.
  • Oncolytic potency of VSV was not perturbed by the IRES modifications.

Conclusions:

  • Picornavirus IRES elements can be effectively engineered into VSV to attenuate neurotoxicity.
  • This strategy offers a promising approach to enhance the safety of VSV-based oncolytic virotherapy.
  • Engineered VSV maintains its efficacy against cancer while exhibiting reduced neuropathogenicity.

Related Concept Videos

Pinching-off of Coated Vesicles01:32

Pinching-off of Coated Vesicles

Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Subviral Agents01:29

Subviral Agents

Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...